NO991358D0 - Anvendelse av sibutramin-analoger for Õ forebygge utvikling av diabetes - Google Patents

Anvendelse av sibutramin-analoger for Õ forebygge utvikling av diabetes

Info

Publication number
NO991358D0
NO991358D0 NO991358A NO991358A NO991358D0 NO 991358 D0 NO991358 D0 NO 991358D0 NO 991358 A NO991358 A NO 991358A NO 991358 A NO991358 A NO 991358A NO 991358 D0 NO991358 D0 NO 991358D0
Authority
NO
Norway
Prior art keywords
diabetes
development
prevent
sibutramine
analogues
Prior art date
Application number
NO991358A
Other languages
English (en)
Norwegian (no)
Other versions
NO991358L (no
Inventor
Clifford James Bailey
Robert Brian Jones
Helen Cristine Jackson
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of NO991358D0 publication Critical patent/NO991358D0/no
Publication of NO991358L publication Critical patent/NO991358L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Electrotherapy Devices (AREA)
NO991358A 1996-09-21 1999-03-19 Anvendelse av sibutramin-analoger for Õ forebygge utvikling av diabetes NO991358L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9619757.9A GB9619757D0 (en) 1996-09-21 1996-09-21 Chemical process
PCT/EP1997/005039 WO1998011884A1 (fr) 1996-09-21 1997-09-15 Utilisation d'analogues de sibutramine pour empecher l'evolution du diabete

Publications (2)

Publication Number Publication Date
NO991358D0 true NO991358D0 (no) 1999-03-19
NO991358L NO991358L (no) 1999-03-19

Family

ID=10800326

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991358A NO991358L (no) 1996-09-21 1999-03-19 Anvendelse av sibutramin-analoger for Õ forebygge utvikling av diabetes

Country Status (26)

Country Link
US (3) US6174925B1 (fr)
EP (1) EP0927028A1 (fr)
JP (1) JP2001503737A (fr)
KR (1) KR20000048501A (fr)
CN (1) CN1237905A (fr)
AU (1) AU724488B2 (fr)
BG (1) BG64473B1 (fr)
BR (1) BR9711517A (fr)
CA (1) CA2266401C (fr)
CZ (1) CZ93699A3 (fr)
GB (1) GB9619757D0 (fr)
HR (1) HRP970505A2 (fr)
HU (1) HUP9904026A3 (fr)
ID (1) ID18320A (fr)
IL (1) IL128850A (fr)
MY (1) MY116150A (fr)
NO (1) NO991358L (fr)
NZ (1) NZ334580A (fr)
PL (1) PL332305A1 (fr)
RU (1) RU2245709C2 (fr)
SK (1) SK31999A3 (fr)
TR (1) TR199900618T2 (fr)
TW (1) TW580385B (fr)
UA (1) UA64726C2 (fr)
WO (1) WO1998011884A1 (fr)
ZA (1) ZA978450B (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9619757D0 (en) * 1996-09-21 1996-11-06 Knoll Ag Chemical process
CA2329004C (fr) * 1998-06-30 2009-04-14 Takeda Chemical Industries, Ltd. Combinaison d'un sensibilisateur a l'insuline et d'un anorexigene pour le traitement ou la prevention du diabete
JP2000080047A (ja) * 1998-06-30 2000-03-21 Takeda Chem Ind Ltd 医 薬
US6331571B1 (en) 1998-08-24 2001-12-18 Sepracor, Inc. Methods of treating and preventing attention deficit disorders
US6974838B2 (en) * 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6476078B2 (en) * 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6339106B1 (en) 1999-08-11 2002-01-15 Sepracor, Inc. Methods and compositions for the treatment and prevention of sexual dysfunction
AR023700A1 (es) * 1998-11-12 2002-09-04 Smithkline Beecham Plc Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina
EA011633B1 (ru) * 1998-11-12 2009-04-28 Смитклайн Бичам Плс Таблетка замедленного высвобождения сенсибилизатора к инсулину и других антидиабетических агентов
US20040102486A1 (en) * 1998-11-12 2004-05-27 Smithkline Beecham Corporation Novel method of treatment
US6696495B2 (en) 1998-12-02 2004-02-24 Snowden Pharmaceuticals, Llc Treatment of disorders secondary to organic impairments
US6323242B1 (en) 1998-12-02 2001-11-27 Peter Sterling Mueller Treatment of disorders secondary to organic impairments
US6552087B1 (en) 1999-03-19 2003-04-22 Abbott Gmbh & Co. Kg Therapeutic agent comprising (+)-sibutramine
US6723717B1 (en) 1999-06-01 2004-04-20 The University Of Texas Southwestern Medical Center Sulfur-containing thyroxane derivatives and their use as hair growth promotors
US6680344B1 (en) 1999-06-01 2004-01-20 The University Of Texas Southwestern Medical Center Method of treating hair loss using diphenylmethane derivatives
WO2000072810A1 (fr) 1999-06-01 2000-12-07 The University Of Texas Southwestern Medical Center Methode de traitement de la perte des cheveux a l'aide de composes de sulfonyle thyromimetiques
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
WO2002083631A1 (fr) 2001-04-13 2002-10-24 Sepracor Inc. Procedes permettant la preparation de didesmethylsibutramine et d'autres derives de sibutramine
US8911781B2 (en) 2002-06-17 2014-12-16 Inventia Healthcare Private Limited Process of manufacture of novel drug delivery system: multilayer tablet composition of thiazolidinedione and biguanides
JP4278652B2 (ja) * 2002-10-05 2009-06-17 ハンミ ファーム． シーオー．， エルティーディー． 結晶性シブトラミンメタンスルホン酸塩半水和物を含む医薬組成物
US20050131074A1 (en) * 2003-08-04 2005-06-16 Beckman Kristen M. Methods for treating metabolic syndrome
UY28457A1 (es) * 2003-08-07 2005-03-31 Sb Pharmco Inc Nueva composición
GB0318824D0 (en) * 2003-08-11 2003-09-10 Glaxo Group Ltd Novel composition
CN1874774B (zh) * 2003-10-31 2011-04-13 武田药品工业株式会社 包含胰岛素致敏剂、胰岛素促分泌素和聚氧乙烯脱水山梨醇脂肪酸酯的固体制剂
KR100627687B1 (ko) * 2005-04-20 2006-09-25 주식회사 씨티씨바이오 시부트라민 유리염기 함유 조성물 및 이의 제조방법
KR101294014B1 (ko) 2006-01-06 2013-08-09 선오비온 파마슈티컬스 인코포레이티드 모노아민 재흡수 저해제로서의 시클로알킬아민
US8604244B2 (en) 2010-07-02 2013-12-10 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
EP2066329B1 (fr) 2006-09-15 2017-09-06 Reviva Pharmaceuticals, Inc. Synthèse, utilisation et compositions de cyclobutylméthylamines
KR100812538B1 (ko) * 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제
CN101528265A (zh) * 2006-11-22 2009-09-09 Sk化学株式会社 西布曲明和β-环糊精的包络物
US8889632B2 (en) 2007-01-31 2014-11-18 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
KR101525754B1 (ko) 2007-03-28 2015-06-09 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 스티칭된 폴리펩티드
CN108570097A (zh) 2010-08-13 2018-09-25 爱勒让治疗公司 拟肽大环化合物
KR20140100937A (ko) 2011-10-18 2014-08-18 에일러론 테라퓨틱스 인코포레이티드 펩티도미메틱 거대고리
WO2013102195A1 (fr) 2011-12-30 2013-07-04 Reviva Pharmaceuticals, Inc. Compositions, synthèses et procédés d'utilisation de dérivés de phénylcycloalkylméthylamine
CN107216380A (zh) 2012-02-15 2017-09-29 爱勒让治疗公司 拟肽大环化合物
CA2864120A1 (fr) 2012-02-15 2013-08-22 Aileron Therapeutics, Inc. Macrocycles peptidomimetiques reticules par triazole et par thioether
CA2887285A1 (fr) 2012-11-01 2014-05-08 Aileron Therapeutics, Inc. Acides amines disubstitues et procedes de preparation et d'utilisation de ceux-ci
CN112245565A (zh) 2014-09-24 2021-01-22 艾瑞朗医疗公司 拟肽大环化合物及其用途
KR20170129879A (ko) 2015-03-20 2017-11-27 에일러론 테라퓨틱스 인코포레이티드 펩티드모방 거대고리 및 이의 용도

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52768B1 (en) * 1981-04-06 1988-02-17 Boots Co Ltd 1-arylcyclobutylalkylamine compounds useful as therapeutic agents
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
GB8704777D0 (en) * 1987-02-28 1987-04-01 Boots Co Plc Medical treatment
JP2675573B2 (ja) * 1988-03-31 1997-11-12 科研製薬株式会社 脳機能改善剤
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
WO1995010292A1 (fr) 1993-10-14 1995-04-20 Biomedica California, Inc. Traitement et prophylaxie du diabete
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment
GB9619757D0 (en) * 1996-09-21 1996-11-06 Knoll Ag Chemical process

Also Published As

Publication number Publication date
US6617360B1 (en) 2003-09-09
CN1237905A (zh) 1999-12-08
MY116150A (en) 2003-11-28
RU2245709C2 (ru) 2005-02-10
BG103277A (en) 2000-01-31
BG64473B1 (bg) 2005-04-30
HRP970505A2 (en) 1998-08-31
ID18320A (id) 1998-03-26
US6174925B1 (en) 2001-01-16
GB9619757D0 (en) 1996-11-06
BR9711517A (pt) 1999-08-24
CA2266401A1 (fr) 1998-03-26
PL332305A1 (en) 1999-08-30
IL128850A0 (en) 2000-01-31
IL128850A (en) 2003-07-31
TR199900618T2 (xx) 1999-06-21
CZ93699A3 (cs) 1999-08-11
SK31999A3 (en) 1999-12-10
AU724488B2 (en) 2000-09-21
UA64726C2 (uk) 2004-03-15
NZ334580A (en) 2000-09-29
AU4774097A (en) 1998-04-14
TW580385B (en) 2004-03-21
NO991358L (no) 1999-03-19
US20040077730A1 (en) 2004-04-22
JP2001503737A (ja) 2001-03-21
HUP9904026A3 (en) 2000-07-28
HUP9904026A2 (hu) 2000-05-28
ZA978450B (en) 1999-03-19
EP0927028A1 (fr) 1999-07-07
WO1998011884A1 (fr) 1998-03-26
KR20000048501A (ko) 2000-07-25
CA2266401C (fr) 2007-01-30

Similar Documents

Publication Publication Date Title
NO991358L (no) Anvendelse av sibutramin-analoger for Õ forebygge utvikling av diabetes
EE03832B1 (et) Heptapeptiidanaloogid
DE69739216D1 (de) Der Entwicklung von konditionierten Reflexen angepasstes System
NO952357D0 (no) Formulering av insulinanaloger
DE69826158D1 (de) Inspektionsgerät für das Aussehen von Kapseln
KR970706248A (ko) 불화된 유기화합물 제조방법(the preparation of fluorinated organic compounds)
NO20001847D0 (no) Ny anvendelse av forbindelser for anti-kløe-aktivitet
DE59701512D1 (de) Mehrprozessor-zentraleinheit
DK0808831T3 (da) Fluorerede vitamin D3-analoger
EE200000055A (et) Protsess tsüklopropüülatsetüleeni valmistamiseks
DE3878868D1 (de) Generator fuer periodische zeitsignale des fractaltyps.
NO972278D0 (no) Fluorerte vitamin D3-analoger
NO20005507D0 (no) Spylerenseapparat
IT1302693B1 (it) Procedimento per il risanamento degli argini
DE69730060D1 (de) Organische-Inorganische Entwicklerzusammensetzung
KR960019736U (ko) 구두바닥의 구조
KR970056574U (ko) 사용이 편한 신발
ITAQ970012A1 (it) Soluzione per risolvere definitivamente la sudorazione dei piedi
UA2227S (uk) Рисунок протектора
ES1040434Y (es) Casa desmontable de uso infantil
KR960033886U (ko) 자동차 앞유리의 부착구조
UA1802S (uk) Рисунок протектора зимовий
KR960007645U (ko) 벨트의 작동상태를 알리기 위한 시스팀
KR950018215U (ko) 주차브레이크 케이블의 선단부 고정구조
LV11766A (lv) Devejs speka merisanai

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application